Xtant Medical Holdings Inc (XTNT)

Currency in USD
0.5699
+0.0174(+3.15%)
Real-time Data·
XTNT Scorecard
Full Analysis
Stock has taken a big hit over the last week
XTNT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.54100.5699
52 wk Range
0.33100.7780
Key Statistics
Prev. Close
0.5525
Open
0.5699
Day's Range
0.541-0.5699
52 wk Range
0.331-0.778
Volume
9.38K
Average Volume (3m)
182.98K
1-Year Change
-17.54%
Book Value / Share
0.32
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
XTNT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
1.7500
Upside
+207.07%
Members' Sentiments
Bearish
Bullish
ProTips
Stock price often moves in the opposite direction of the market

Xtant Medical Holdings Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Buy
Moving Averages
Sell

Xtant Medical Holdings Inc Company Profile

Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. The company offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, which can be compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated and terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, an aseptically processed and viable bone allograft; and nanOss products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also provides sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. In addition, the company offers cervical products comprising Spider cervical plating, Streamline OCT, and CervAlign systems; thoracolumbar products consisting of Axle-X interspinous fusion, Streamline MIS spinal fixation, Streamline TL spinal fixation, and HPS 2.0 hybrid performance systems; and Silex sacroiliac joint fusion systems. Further, it provides interbody products comprising Calix for cervical and thoracolumbar applications, Irix-C Cervical and Irix-A lumbar integrated dusion systems, and Fortilink implants; and interlaminar stabilization products, such as Coflex device for lumbar spinal stenosis; and CoFix implants for back and disc pain. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.

Xtant Medical Holdings Inc Earnings Call Summary for Q1/2025

  • Revenue rose 18% YoY to $32.9M, beating forecasts by $1.3M; net income of $58K vs $4.4M loss in Q1 2024
  • Stock surged 15.38% in after-hours trading to $0.60, approaching 52-week high of $0.846
  • FY2025 revenue guidance: $127M-$131M, projecting 8-11% growth; company expects to achieve self-sustainability
  • Two new products launched; processing capacity expanded; restrictive investor rights agreement terminated
  • CEO highlighted Xtant as 'most diversified, vertically integrated biologics company in the market'
Last Updated: 12/05/2025, 22:08
Read Full Transcript

Compare XTNT to Peers and Sector

Metrics to compare
XTNT
Peers
Sector
Relationship
P/E Ratio
−6.6x−11.8x−0.5x
PEG Ratio
0.01−0.290.00
Price/Book
1.8x2.8x2.6x
Price / LTM Sales
0.6x3.1x3.3x
Upside (Analyst Target)
216.7%73.0%43.5%
Fair Value Upside
Unlock4.3%6.3%Unlock

Analyst Ratings

1 Buy
0 Hold
1 Sell
Ratings:
2 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 1.7500
(+207.07% Upside)

Earnings

Latest Release
May 12, 2025
EPS / Forecast
0.2791 / -0.01
Revenue / Forecast
32.90M / 31.58M
EPS Revisions
Last 90 days

XTNT Income Statement

People Also Watch

0.430
ADIL
+3.61%
37.16
EXEL
+0.95%
25.02
VCYT
+2.86%
1.460
QSI
+1.39%
0.3528
VXRT
-4.64%

FAQ

What Stock Exchange Does Xtant Medical Trade On?

Xtant Medical is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for Xtant Medical?

The stock symbol for Xtant Medical is "XTNT."

What Is the Xtant Medical Market Cap?

As of today, Xtant Medical market cap is 79.40M.

What Is Xtant Medical's Earnings Per Share (TTM)?

The Xtant Medical EPS (TTM) is -0.09.

When Is the Next Xtant Medical Earnings Date?

Xtant Medical will release its next earnings report on 29 Oct 2025.

From a Technical Analysis Perspective, Is XTNT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Xtant Medical Stock Split?

Xtant Medical has split 2 times.

How Many Employees Does Xtant Medical Have?

Xtant Medical has 225 employees.

What is the current trading status of Xtant Medical (XTNT)?

As of 05 Aug 2025, Xtant Medical (XTNT) is trading at a price of 0.57, with a previous close of 0.55. The stock has fluctuated within a day range of 0.54 to 0.57, while its 52-week range spans from 0.33 to 0.78.

What Is Xtant Medical (XTNT) Price Target According to Analysts?

The average 12-month price target for Xtant Medical is USD1.75, with a high estimate of USD2 and a low estimate of USD1.5. 1 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Neutral. The stock has an +207.07% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.